Evidence map›Paper›PMID 34697046›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2021

Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remains.

Anna van der Vossen, Sandra Buljaç, Kadir Akçay, Jan Dietert Brugma, Arnold Vulto, Lidwien Hanff

Abstract read
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Improving Availability of Pediatric Formulations.Indian journal of pediatrics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna van der VossenDepartment of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID 0000-0003-3300-7084
Sandra BuljaçDepartment of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
Kadir AkçayDepartment of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
Jan Dietert BrugmaDepartment of Outpatient Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands j.brugma@erasmusmc.nl.
Arnold VultoDepartment of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
Lidwien HanffDepartment of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo quantify the availability of authorised, age-appropriate paediatric medicines in clinical practice in the Netherlands and to identify gaps by assessing dispensing practice in a paediatric hospital.

methodsThe availability of age-appropriate formulations was assessed by conducting a survey on the use of pharmacy compounded medicines among the paediatric hospitals in the Netherlands, and by analysing dispensing data of oral medication from the inpatient pharmacy of the largest paediatric hospital in the Netherlands. The age-appropriateness of the dispensed formulations was assessed on two aspects: dose-capability and acceptability. Liquid drug products that are unsuitable due to the presence of potentially harmful excipients, were identified based on the dosage in clinical practice.

resultsFor 129 out of 139 drug substances included in the survey (93%), at least one of the eight respondents stated to use a pharmacy compounded product to meet the needs of their paediatric patients. The age-appropriateness of medicines dispensed from the inpatient pharmacy increased with age, and was higher for non-intensive care unit (ICU) patients than for ICU patients. We identified 15 drug products causing excipient exposure above the European Medicines Agency-recommended values.

conclusionsThis study confirms there is still a large need for age-appropriate formulations in daily clinical practice. Pharmacy compounding for paediatric patients remains essential for many indications. The need for potentially harmful excipients in compounded products should be critically assessed.

Indexed as

Pharmaceutical ServicesPharmacyChildDrug CompoundingHumansNetherlandsSurveys and Questionnairesavailabilitycompoundingexcipientspaediatric formulations

Identifiers

PMID34697046
PMCPMC8552141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.